Binding mode of 6ECDCA, a potent bile acid agonist of the Farnesoid X Receptor (FXR)

被引：23

作者：

Costantino, G ^{[1
]}

Macchiarulo, A ^{[1
]}

Entrena-Guadix, A ^{[1
]}

Camaioni, E ^{[1
]}

Pellicciari, R ^{[1
]}

机构：

[1] Univ Perugia, Dipartimento Chim & Tecnol Farmaco, I-06123 Perugia, Italy

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2003年 / 13卷 / 11期

关键词：

D O I：

10.1016/S0960-894X(03)00281-6

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

Based on the folding conservation across the nuclear receptor superfamily and the sequence homology with RAR-gamma, we report the construction of a three dimensional model of the ligand binding domain of FXR. The model is exploited for the elucidation of the binding mode of 6alpha-ethyl-chenodeoxycholic acid. The results of the docking experiments give quite clear indications that the bile acid derivative would bind the receptor in a mode significantly different than that observed for agonists of other nuclear receptor superfamily. (C) 2003 Elsevier Science Ltd. All rights reserved.

引用

页码：1865 / 1868

页数：4

共 25 条

[11] Identification of a nuclear receptor for bile acids [J].

Makishima, M ;

Okamoto, AY ;

Repa, JJ ;

Tu, H ;

Learned, RM ;

Luk, A ;

Hull, MV ;

Lustig, KD ;

Mangelsdorf, DJ ;

Shan, B .

SCIENCE, 1999, 284 (5418) :1362-1365

[12]

Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO

[13]

2-B

[14] Ligand binding and co-activator assembly of the peroxisome proliferator-activated receptor-γ [J].

Nolte, RT ;

Wisely, GB ;

Westin, S ;

Cobb, JE ;

Lambert, MH ;

Kurokawa, R ;

Rosenfeld, MG ;

Willson, TM ;

Glass, CK ;

Milburn, MV .

NATURE, 1998, 395 (6698) :137-143

[15] Bile acids: Natural ligands for an orphan nuclear receptor [J].

Parks, DJ ;

Blanchard, SG ;

Bledsoe, RK ;

Chandra, G ;

Consler, TG ;

Kliewer, SA ;

Stimmel, JB ;

Willson, TM ;

Zavacki, AM ;

Moore, DD ;

Lehmann, JM .

SCIENCE, 1999, 284 (5418) :1365-1368

[16] 6α-ethyl-chenodeoxycholic acid (6-ECDCA), a potent and selective FXR agonist endowed with anticholestatic activity [J].

Pellicciari, R ;

Fiorucci, S ;

Camaioni, E ;

Clerici, C ;

Costantino, G ;

Maloney, PR ;

Morelli, A ;

Parks, DJ ;

Willson, TM .

JOURNAL OF MEDICINAL CHEMISTRY, 2002, 45 (17) :3569-3572

[17] UFF, A FULL PERIODIC-TABLE FORCE-FIELD FOR MOLECULAR MECHANICS AND MOLECULAR-DYNAMICS SIMULATIONS [J].

RAPPE, AK ;

CASEWIT, CJ ;

COLWELL, KS ;

GODDARD, WA ;

SKIFF, WM .

JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1992, 114 (25) :10024-10035

[18] CRYSTAL-STRUCTURE OF THE RAR-GAMMA LIGAND-BINDING DOMAIN BOUND TO ALL-TRANS-RETINOIC ACID [J].

RENAUD, JP ;

ROCHEL, N ;

RUFF, M ;

VIVAT, V ;

CHAMBON, P ;

GRONEMEYER, H ;

MORAS, D .

NATURE, 1995, 378 (6558) :681-689

[19] Pharmacophore analysis of the nuclear oxysterol receptor LXRα [J].

Spencer, TA ;

Li, DS ;

Russel, JS ;

Collins, JL ;

Bledsoe, RK ;

Consler, TG ;

Moore, LB ;

Galardi, CM ;

McKee, DD ;

Moore, JT ;

Watson, MA ;

Parks, DJ ;

Lambert, MH ;

Willson, TM .

JOURNAL OF MEDICINAL CHEMISTRY, 2001, 44 (06) :886-897

[20] The important role of residue F268 in ligand binding by LXRβ [J].

Urban, F ;

Cavazos, G ;

Dunbar, J ;

Tan, B ;

Escher, P ;

Tafuri, S ;

Wang, MH .

FEBS LETTERS, 2000, 484 (02) :159-163

← 1 2 3 →